ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1381

Health Related Quality of Life in Children with Systemic Lupus Erythematosus

Julie Samuels1, Rula Issa2, Lauren Robinson3 and Rebecca Trachtman1, 1Icahn School of Medicine at Mount Sinai, New York, NY, 2Phillips School of Nursing at Mount Sinai, New York, NY, 3Hospital for Special Surgery/New York Presbyterian-Weill Cornell, New York, NY

Meeting: ACR Convergence 2022

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: The importance of patient-reported outcomes and health-related quality of life (HRQOL) is increasingly recognized in healthcare. Adults with Systemic Lupus Erythematosus (SLE) have poor HRQOL, which is associated with medication non-adherence and worse medical outcomes [1,2]. Studies suggest that young adults with SLE endorse having limited physical and social capabilities, however, there is a paucity of research regarding HRQOL in children with SLE [3, 4]. In this study we aimed to measure HRQOL in children with SLE, hypothesizing that those with worse HRQOL will have higher disease activity.

Methods: A convenience sample of 19 children with SLE were consecutively recruited between 8/20/2019 and 3/31/2022. Subjects completed the Patient global health assessment (PtGA) and pediatric Patient Reported Outcomes Measurement Information System (PROMIS) questionnaires [5]. PROMIS domains collected as both short forms (SF) and computer adaptive tests (CATS) were: Anxiety, Depression, Fatigue, Pain interference, Peer relationships, Physical activity, and Mobility; each having a mean of 50 and a standard deviation (SD) of 10 for the general population [6]. The treating physician completed the Physician global health assessment (PhGA) and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Descriptive statistics was calculated. Using standard software, raw scores for PROMIS measures were converted to T-scores. Spearman’s correlations were performed with statistical significance set to p< 0.05.

Results: In our population, median SLEDAI was 6 [IQR 4,12] indicating overall moderate disease activity. All PROMIS domains were within 1 SD of the mean. All PROMIS SF and CATs for the same domain were strongly correlated (r ≥ 0.80, p< 0.01, Table 3). PhGA was strongly correlated with SLEDAI (r = 0.75, p=0.00038), but did not correlate with any PROMIS domains, aside from Peer Relationships. PtGA was strongly correlated with PROMIS Anxiety (r = -0.73, p = 0.00042), and moderately correlated with Depression (r = -0.62, p = 0.00476), Pain interference (r = -0.51, p = 0.025), Peer relationships (r = 0.48, p = 0.043), and Mobility (r = 0.56, p = 0.012), but was not correlated with additional PROMIS domains or SLEDAI (Table 2). SLEDAI was not correlated with any PROMIS measures

Conclusion: All PROMIS domains in our cohort were within 1 SD of the mean, suggesting that HRQOL in children with SLE does not significantly differ from the general population. The strong association between PROMIS SF and PROMIS CATS show that CATS are a reliable metric to assess HRQOL. The correlations between Anxiety, Depression, Pain Interference, and Mobility PROMIS domains with the PtGA suggest that the overall wellbeing of children with SLE may be particularly impacted by these four domains. There were no significant correlations between the PROMIS measures and SLEDAI nor PhGA, suggesting that HRQOL is not related to disease activity in this population. This study is limited by small sample size in a single center; additional research is needed to further characterize the HRQOL of children with SLE, including studies examining the drivers of high and low HRQOL as well as ways to improve HRQOL in this population.

Supporting image 1

Figure 1. PROMIS Short Form Domains

Supporting image 2

Table 1. Patient Characteristics

Supporting image 3

Table 2. Spearman Correlation Coefficients comparing PROMIS Short Form Domains and Standard Instruments
*bolded R value signifies p<0.05


Disclosures: J. Samuels, None; R. Issa, None; L. Robinson, None; R. Trachtman, None.

To cite this abstract in AMA style:

Samuels J, Issa R, Robinson L, Trachtman R. Health Related Quality of Life in Children with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/health-related-quality-of-life-in-children-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-related-quality-of-life-in-children-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology